Zika Virus Seropositivity in 1–4-Year-Old Children, Indonesia, 2014
R. Tedjo Sasmonoa b c d✉, Rama Dhennia b c d, Benediktus Yohana b c d, Paul Pronyka b, Sri Rezeki Hadinegorob, Elizabeth Jane Soepardib e, Chairin Nisa Ma’roefb, Hindra Irawan Satarib f g h, Heather Menziesb, William A. Hawleyb, Ann M. Powersb i, Ronald Rosenbergb, Khin Saw Aye Myinta b, Amin Soebandrioa c d
- aUniversity of Witwatersrand School of Public Health , Johannesburg , South Africa ( P. Pronyk)
- bEijkman Institute for Molecular Biology, Jakarta, Indonesia
- cUNICEF Indonesia, Jakarta (P. Pronyk)
- dUniversity of Witwatersrand School of Public Health, Johannesburg, South Africa (P. Pronyk)
- eEijkman Institute for Molecular Biology , Jakarta , Indonesia
- fCipto Mangunkusumo Hospital , Jakarta (S
- gMangunkusumo Hospital, Jakarta
- hUniversitas Indonesia Medical School, Jakarta
- iCenters for Disease Control and Prevention, Fort Collins, Colorado, USA
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
We assessed Zika virus seroprevalence among healthy 1-4-year-old children using a serum sample collection assembled in 2014 representing 30 urban sites across Indonesia. Of 662 samples, 9.1% were Zika virus seropositive, suggesting widespread recent Zika virus transmission and immunity. Larger studies are needed to better determine endemicity in Indonesia.